Page 143 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Genetic Aspects of Vasculitis 119

[193] Shahram, F., Nikoopour, E., Rezaei, N., et al. Association of interleukin-2, interleukin-
4 and transforming growth factor-beta gene polymorphisms with Behçet's disease. Clin.
Exp. Rheumatol. 2011; 29:S28-31.

[194] Kim, S. K., Jang, W. C., Ahn, Y. C., et al. Promoter -2518 single nucleotide
polymorphism of monocyte chemoattractant protein-1 is associated with clinical
severity in Behçet's disease. Inflamm. Res. 2012; 61:541-545.

[195] Saadat, M. Association between K469E polymorphism of intracellular adhesion
molecules-1 ICAM-1 and Behçet's disease. Saudi Med. J. 2006; 27:1934.

[196] Boiardi, L., Salvarani, C., Casali, B., et al. Intercellular adhesion molecule-1 gene
polymorphisms in Behçet's Disease. J. Rheumatol. 2001; 28:1283-1287.

[197] Verity, D. H., Vaughan, R. W., Kondeatis, E., et al. Intercellular adhesion molecule-1
gene polymorphisms in Behçet's disease. Eur. J. Immunogenet. 2000; 27:73-76.

[198] Kim, E. H., Mok, J. W., Bang, D. S., et al. Intercellular adhesion molecule-1
polymorphisms in Korean patients with Behçet s disease. J. Korean Med. Sci. 2003; 18:
415-418.

[199] Lee, Y. J., Kang, S. W., Baek, H. J., et al. Association between matrix
metalloproteinase 9 promoter polymorphisms and Behçet's disease. Hum. Immunol.
2010; 71:717-722.

[200] Kim, J. U., Chang, H. K., Lee, S. S., et al. Endothelial nitric oxide synthase gene
polymorphisms in Behçet's disease and rheumatic diseases with vasculitis. Ann. Rheum.
Dis. 2003; 62:1083-1087.

[201] Salvarani, C., Boiardi, L., Casali, B., et al. Vascular endothelial growth factor gene
polymorphisms in Behçet's disease. J. Rheumatol. 2004; 31:1785-1789.

[202] Tursen, U., Tamer, L., Eskandari, G., et al. Glutathione S-transferase polymorphisms in
patients with Behçet's disease. Arch. Dermatol. Res. 2004; 296:185-187.

[203] Lee, Y. J., Kang, S. W., Song, J. K., et al. Associations between interferon regulatory
factor-1 polymorphisms and Behçet's disease. Hum. Immunol. 2007; 68:770-778.

[204] Hou, S., Kijlstra, A., Yang, P. The genetics of Behçet's disease in a Chinese population.
Front Med. 2012; 6:354-359.

[205] Ben Dhifallah, I., Chelbi, H., Braham, A., et al. CTLA-4 +49A/G polymorphism is
associated with Behçet's disease in a Tunisian population. Tissue Antigens 2009; 73:
213-217.

[206] Du, L., Yang, P., Hou, S., et al. No association of CTLA-4 polymorphisms with
susceptibility to Behçet disease. Br. J. Ophthalmol. 2009; 93:1378-1381.

[207] Duzgun, N., Duman, T., Keskin, O., et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4)
polymorphism in patients with Behçet's disease. Clin. Exp. Rheum. 2010; 28:S100.

[208] Gunesacar, R., Erken, E., Bozkurt, B., et al. Analysis of CD28 and CTLA-4 gene
polymorphisms in Turkish patients with Behçet's disease. Int. J. Immunogenet. 2007;
34:45-49.

[209] Yalcin, B., Atakan, N., Alli, N. The functional role of nuclear factor kappa-kappaB1 -
94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory
study. Clin. Exp. Dermatol. 2008; 33:629-633.

[210] Amoura, Z., Dode, C., Hue, S., et al. Association of the R92Q TNFRSF1A mutation
and extracranial deep vein thrombosis in patients with Behçet's disease. Arthritis
Rheum. 2005; 52:608-611.

Complimentary Contributor Copy